EUVIMEDEUVIMED entdecken
Crossref

Challenges and considerations in multi-epitope vaccine design surrounding toll-like receptors

Masaud Shah, Sobia Rafiq, Hyun G Woo

Trends in Pharmacological Sciences · 2024-12 · 45 (12) · 1104-1118

DOI: 10.1016/j.tips.2024.10.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Pharmacological Sciences, 2024-12. Verfasst von Masaud Shah und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Ajou University School of Medicine, Suwon 16499, Republic of Korea; Ajou Translational Omics Center (ATOC), Research Instit…. Hauptthemen laut MEDLINE: Epitopes, Toll-Like Receptors. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 103 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epitope-based peptide vaccines elicit targeted immune responses, making them effective for diseases requiring focused immune activation, such as targeting cancer-associated antigens. Strategies like peptide cocktails and mRNA-based epitope vaccines have revolutionized the field; however, the term 'multi-epitope peptide vaccine' has been overextended, especially concerning the use of toll-like receptors (TLRs), their ligands, and peptide linkers. TLRs are often conflated with T cell receptors (TCRs) and B cell receptors (BCRs), which recognize immunogenic peptides within vaccines. This Opinion clarifies the role of TLRs and highlights challenges linked to their indiscriminate use in multi-epitope vaccine design. While peptide linkers are crucial in creating multivalent vaccines, their unsupervised application is increasing and warrants attention. After highlighting their role in advancing peptide vaccines, we discuss critical factors in linker implementation and caution against their misuse, which could undermine vaccines' efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpitopesToll-Like ReceptorsAnimalsHumansReceptors, Antigen, T-CellVaccines, Subunit

Stichwörter der Autor:innen

adjuvantmulti-epitopepeptidetoll-like receptorvaccine

Substanzen

EpitopesReceptors, Antigen, T-CellToll-Like ReceptorsVaccines, Subunit

Autor:innen und Institutionen

  • Department of Physiology, Ajou University School of Medicine, Suwon 16499, Republic of Korea; Ajou Translational Omics Center (ATOC), Research Institute for Innovative Medicine, Ajou University Medical Center, Suwon, Re…
  • Department of Physiology, Ajou University School of Medicine, Suwon 16499, Republic of Korea.

Zitieren

APA

Shah, M., Rafiq, S., & Woo, H. G. (2024). Challenges and considerations in multi-epitope vaccine design surrounding toll-like receptors. Trends in Pharmacological Sciences, 45(12), 1104-1118. https://doi.org/10.1016/j.tips.2024.10.013

Vancouver

Shah M, Rafiq S, Woo HG. Challenges and considerations in multi-epitope vaccine design surrounding toll-like receptors. Trends in Pharmacological Sciences. 2024;45(12):1104-1118. doi:10.1016/j.tips.2024.10.013

BibTeX
@article{Shah2024,
  author = {Shah, Masaud and Rafiq, Sobia and Woo, Hyun G},
  title = {Challenges and considerations in multi-epitope vaccine design surrounding toll-like receptors},
  journal = {Trends in Pharmacological Sciences},
  year = {2024},
  volume = {45},
  number = {12},
  pages = {1104--1118},
  doi = {10.1016/j.tips.2024.10.013}
}
Kostenlos starten →